ZIU:CA:TSX-BMO S&P/TSX 60 Index ETF (CAD)

ETF | Others |

Last Closing

CAD 57.78

Change

+0.13 (+0.23)%

Market Cap

CAD 0.07B

Volume

1.34K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.01 (-0.01%)

CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

N/A

CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

N/A

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.12 (+0.32%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.26 (-0.56%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.41 (+1.71%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.15 (+1.45%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.01 (-0.04%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 2.68B

ETFs Containing ZIU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.91% 69% C- 68% D+
Dividend Return 2.37% 46% F 35% F
Total Return 21.28% 67% D+ 66% D+
Trailing 12 Months  
Capital Gain 23.51% 69% C- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.51% 60% D- 59% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.66% 53% F 45% F
Dividend Return 2.66% 52% F 38% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.90% 57% F 79% B-
Risk Adjusted Return 33.66% 52% F 50% F
Market Capitalization 0.07B 57% F 30% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike